Today
+2.44%
5 Days
+5.71%
1 Month
-1.97%
6 Months
+71.01%
Year to Date
+59.83%
1 Year
+157.01%
• Product safety concerns and regulatory scrutiny impact share price. • Challenges in China and Japan markets affect international growth. • Institutional investors reduced stakes, contributing to price decline.
• CVS Health stock rose with strong earnings outlook and analyst support. • Favorable Medicare Advantage payment rates aid Aetna's earnings backdrop. • FTC insulin pricing settlement reduces regulatory uncertainty.


| Shareholders | Proportion |
|---|---|
| AQR Capital Management, LLC | 6.44% |
| Vanguard Capital Management, LLC | 6.33% |
| BlackRock Institutional Trust Company, N.A. | 5.31% |
| Vanguard Portfolio Management, LLC | 4.38% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 42.40% |
| Investment Advisor/Hedge Fund | 34.39% |
| Hedge Fund | 11.71% |
| Research Firm | 3.76% |
Related Instruments
Popular Instruments